|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Jan 31, 2025
|
FY2024
12 months to Jan 31, 2024
|
FY2023
12 months to Jan 31, 2023
|
FY2022
12 months to Jan 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||
| Depreciation and amortization | |||||
| Amortization of deferred contract acquisition and fulfillment costs | |||||
| Amortization of debt discount and transaction costs | |||||
| Non-cash operating lease costs | |||||
| Stock-based compensation expense | |||||
| Deferred income taxes | |||||
| Other | |||||
| Changes in operating assets and liabilities | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Deferred contract acquisition and fulfillment costs | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Accrued compensation | |||||
| Contract liabilities | |||||
| Operating lease liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Cash paid for acquisition, net of acquired cash | |||||
| Purchases of marketable securities | |||||
| Sales of marketable securities | |||||
| Maturities of marketable securities | |||||
| Purchases of strategic and other investments | |||||
| Purchases of property and equipment | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Repayments of convertible senior notes | |||||
| Payment of revolving credit facility costs | |||||
| Repurchases of common stock | |||||
| Settlement of capped calls, net of related costs | |||||
| Payment of tax withholding obligation on net RSU settlement and ESPP purchase | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from employee stock purchase plan | |||||
| Net cash used in financing activities | |||||
| Effect of foreign exchange on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosure: | |||||
| Cash paid for interest | |||||
| Cash paid for operating lease liabilities | |||||
| Cash paid for income taxes | |||||
| Non-cash investing and financing activities: | |||||
| Property and equipment in accounts payable and accrued expenses and other current liabilities | |||||
| Operating lease right-of-use assets exchanged for lease obligations | |||||
| Excise tax payable on net stock repurchase | |||||
| Fair value of shares issued as part of the repayments of convertible senior notes | |||||
| Repurchases of common stock in accrued expenses and other current liabilities | |||||
Loading...